Has Bhaktasharan Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,978,364 in general payments to Bhaktasharan Patel, MD across 1,946 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bhaktasharan Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bhaktasharan Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bhaktasharan Patel, MD

Gastroenterology · Colorado Springs, CONPI 1053415463

Payments from drug & device makers

$21,978,364in general payments, 2019–2025

Across 1,946 payments — averaging $11,294 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron$13.3M
AbbVie$1.7M
Pfizer$1.1M
Janssen Research & Development, LLC$1M
Novartis$809K
Boehringer Ingelheim$599K
plus $3.5M from 45 others

$294,564in research payments, 2019–2025

Across 25 payments — averaging $11,783 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$290K
AbbVie$3K
Ipsen Bioscience Inc.$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron	238	$13,271,616
AbbVie(2 entities)	319	$1,748,040
Pfizer(2 entities)	191	$1,056,424
Janssen Research & Development, LLC	175	$1,008,040
Novartis	3	$808,791
Boehringer Ingelheim	9	$598,988
GSK	80	$541,189
E.r. Squibb & Sons, L.L.C.	6	$479,874
AstraZeneca	14	$391,960
Intercept Pharmaceuticals, Inc.	47	$384,627
Bristol Myers Squibb	29	$289,965
Teva Pharmaceuticals USA, Inc.	31	$220,837
Ipsen Bioscience Inc.	86	$173,611
Eli Lilly	6	$158,444
Boehringer Ingelheim International GmbH	235	$156,835
Takeda Pharmaceuticals U.S.A., Inc.	82	$153,585
Genentech, Inc.	55	$97,827
Bausch Health US, LLC	45	$77,647
Merck	17	$77,151
Gilead	44	$60,210
Adare Pharmaceuticals, Inc.	7	$58,453
Roche Products Limited	27	$57,666
Shire North American Group Inc	10	$29,000
F. Hoffmann-la Roche AG	1	$21,525
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$18,000
Boehringer Ingelheim RCV GmbH & Co KG	36	$16,913
Ironwood Pharmaceuticals, Inc	5	$14,295
Enterra Medical, Inc.	14	$2,193
Boston Scientific	10	$828
Sanofi	26	$756
Lilly USA, LLC	18	$513
Janssen Scientific Affairs, LLC	6	$470
Johnson & Johnson	18	$457
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	10	$356
Madrigal Pharmaceuticals	4	$252
Ardelyx, Inc.	6	$189
Medtronic(2 entities)	3	$127
QOL Medical, LLC	6	$102
Ferring Pharmaceuticals Inc.	6	$96
Ipsen Biopharmaceuticals, Inc	3	$85
Fujifilm Healthcare Americas Corporation	1	$85
Novo Nordisk	3	$84
Aimmune Therapeutics, Inc.	3	$59
Mauna Kea Technologies, Inc.	1	$57
Celltrion USA Inc.	2	$32
Regeneron Healthcare Solutions, Inc.	1	$25
Micro-tech Endoscopy USA, Inc.	1	$23
Laborie Medical Technologies Corp.	1	$20
Nestle Healthcare Nutrition Inc.	1	$16
Braintree Laboratories, Inc.	1	$15
Phathom Pharmaceuticals, Inc.	1	$14

How this compares

$21,978,364 in reported general payments places this provider in the 95th percentile of 304 gastroenterology providers in Colorado.

See all gastroenterology providers in Colorado →

Medicare billing

Part B allowed, 2024

$201,154

Medicare patients

611

Services billed

2,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Colorado Springs

Douglas AdlerColorado Springs$1.2M
Thomas WeltonColorado Springs$182K
Diana ArseneColorado Springs$61K
Bryan KavanaughColorado Springs$26K
Lukasz KowalczykColorado Springs$25K
Thomas MeisterColorado Springs$17K
Marcelo KugelmasEnglewood$2.7M
Masi KhajaGrand Junction$1.2M
Peter McNallyFt Carson$1.1M
Mark GerichAurora$1M

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →